OLA
Oliver Luxxe Assets Portfolio holdings
AUM
$668M
1-Year Est. Return
40.29%
This Fund
S&P 500
1 Year Est. Return
+40.29%
AUM
$668M
AUM Growth
+$10.9M
(+1.7%)
Holding
220
Top Buys
| 1 | +$8.55M | |
| 2 | +$7.16M | |
| 3 | +$7.12M | |
| 4 |
Salesforce
CRM
|
+$6.55M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$5.47M |
Top Sells
| 1 | +$10.6M | |
| 2 | +$8.92M | |
| 3 | +$8.41M | |
| 4 |
Amazon
AMZN
|
+$8.1M |
| 5 |
Smith & Nephew
SNN
|
+$5.94M |
Sector Composition
| 1 | Financials | 18.1% |
| 2 | Industrials | 15.85% |
| 3 | Technology | 13.46% |
| 4 | Healthcare | 9.05% |
| 5 | Energy | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Bank OZK
OZK
$5.38B
| – | – |
-49,178
|
|
||
202
Primoris Services
PRIM
$8.94B
| – | – |
-19,888
|
|
||
203
Axcelis
ACLS
$3.65B
| – | – |
-18,063
|
|
||
204
Addus HomeCare
ADUS
$1.76B
| – | – |
-18,115
|
|
||
205
Alkermes
ALKS
$5.74B
| – | – |
-56,031
|
|
||
206
AstraZeneca
AZN
$318B
| – | – |
-91,468
|
|
||
207
Celestica
CLS
$45.5B
| – | – |
-13,836
|
|
||
208
Charles River Laboratories
CRL
$9.07B
| – | – |
-10,284
|
|
||
209
Dorman Products
DORM
$3.33B
| – | – |
-15,300
|
|
||
210
Encompass Health
EHC
$10.6B
| – | – |
-31,137
|
|
||
211
Hawkins
HWKN
$3.16B
| – | – |
-15,158
|
|
||
212
Intuit
INTU
$109B
| – | – |
-450
|
|
||
213
Lumentum
LITE
$63.8B
| – | – |
-1,301
|
|
||
214
3M
MMM
$80.7B
| – | – |
-65,944
|
|
||
215
Newmark Group
NMRK
$3.05B
| – | – |
-109,427
|
|
||
216
Tanger
SKT
$4.24B
| – | – |
-55,590
|
|
||
|
217
Smith & Nephew
SNN
$14.7B
| – | – |
-181,116
|
|
||
|
SNV
218
DELISTED
Synovus
SNV
| – | – |
-102,190
|
|
||
219
WESCO International
WCC
$15.5B
| – | – |
-21,094
|
|
||
220
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.4B
| – | – |
-2,587
|
|